We are live on ! Find out more
CCA

Catalyst Capital Advisors Portfolio holdings

AUM $6.03B
1-Year Est. Return 24.5%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$2.87B
AUM Growth
+$187M
Cap. Flow
-$176M
Cap. Flow %
-6.14%
Top 10 Hldgs %
64.21%
Holding
508
New
96
Increased
109
Reduced
110
Closed
117

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$17.3M
2
A icon
Agilent Technologies
A
+$12.8M
3
WOLF icon
Wolfspeed
WOLF
+$11.1M
4
SPR
Spirit AeroSystems
SPR
+$8.74M
5
PG icon
Procter & Gamble
PG
+$7.3M

Top Sells

Rank Stock Value
1
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$32.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$27.8M
3
AMGN icon
Amgen
AMGN
+$22.1M
4
VB icon
Vanguard Small-Cap ETF
VB
+$18.3M
5
AXP icon
American Express
AXP
+$16.2M

Sector Composition

Rank Sector Weight
1 Energy 7.81%
2 Technology 4.09%
3 Healthcare 3.02%
4 Industrials 2.34%
5 Consumer Discretionary 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALTR
376
DELISTED
Altair Engineering Inc
ALTR
$4K ﹤0.01%
102
-7
-6% -$235
HARP
377
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$4K ﹤0.01%
+47
New +$6.18K
EVOP
378
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$4K ﹤0.01%
124
– –
SAIL
379
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$4K ﹤0.01%
130
+15
+13% +$427
LAIX
380
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$4K ﹤0.01%
32
– –
AKCA
381
DELISTED
Akcea Therapeutics Inc
AKCA
$4K ﹤0.01%
135
+15
+13% +$437
APPN icon
382
Appian
APPN
$1.74B
$3K ﹤0.01%
100
– –
CMMB
383
Chemomab Therapeutics
CMMB
$9.97M
$3K ﹤0.01%
+8
New +$4.05K
RGNX icon
384
Regenxbio
RGNX
$623M
$3K ﹤0.01%
+55
New +$2.73K
UPWK icon
385
Upwork
UPWK
$1.09B
$3K ﹤0.01%
165
-115
-41% -$2.36K
YETI icon
386
Yeti Holdings
YETI
$3.82B
$3K ﹤0.01%
105
-295
-74% -$6.42K
GSKY
387
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$3K ﹤0.01%
+270
New +$3.08K
ACA icon
388
Arcosa
ACA
$7.12B
$2K ﹤0.01%
80
-220
-73% -$6.72K
RUN icon
389
Sunrun
RUN
$2.37B
$2K ﹤0.01%
162
– –
XYF
390
X Financial
XYF
$184M
$2K ﹤0.01%
140
– –
ABBV icon
391
AbbVie
ABBV
$458B
– –
-1,900
Closed -$175K
ALLK
392
DELISTED
Allakos
ALLK
– –
-59
Closed -$3K
AMAL icon
393
Amalgamated Financial
AMAL
$1.48B
– –
-375
Closed -$7K
AMGN icon
394
Amgen
AMGN
$203B
– –
-113,685
Closed -$22.1M
AWK icon
395
American Water Works
AWK
$26.3B
– –
-23,900
Closed -$2.17M
AXP icon
396
American Express
AXP
$223B
– –
-170,000
Closed -$16.2M
BA icon
397
Boeing
BA
$165B
– –
-13,110
Closed -$4.23M
BLK icon
398
Blackrock
BLK
$164B
– –
-600
Closed -$236K
BR icon
399
Broadridge
BR
$17.2B
– –
-36,117
Closed -$3.48M
BRK.B icon
400
Berkshire Hathaway Class B
BRK.B
$1.07T
– –
-3,350
Closed -$684K
14 15
16
17 18

Similar funds

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return

Catalyst Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Catalyst Capital Advisors held 508 positions worth $2.87B, up 7% from $2.68B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Catalyst Capital Advisors withdrew a net $176M in Q1 2019, closing 117 positions and reducing 110 holdings. Its most notable exit was Amgen, an estimated $22.1M position sold in full.

By sector, the portfolio is most concentrated in Energy at 7.8% of assets, up from 6.1% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Catalyst Capital Advisors opened a new position in Aflac worth $18M.

  • Catalyst Capital Advisors's largest Q1 2019 buy was Aflac: 360,000 shares worth $18M.
  • Catalyst Capital Advisors added most to Agilent Technologies in Q1 2019, an estimated $12.8M increase.
  • Catalyst Capital Advisors's biggest Q1 2019 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $32.4M.
  • Catalyst Capital Advisors fully exited Amgen in Q1 2019, selling an estimated $22.1M.
  • Catalyst Capital Advisors's ten largest holdings make up 64% of its $2.87B portfolio in Q1 2019.
  • Catalyst Capital Advisors opened 96 new positions and closed 117 in Q1 2019.
  • Catalyst Capital Advisors's portfolio value rose 7% quarter-over-quarter to $2.87B.

Based on Catalyst Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.